Larry A. Law
Brian Hooker, Ph.D., Children's Health Defense chief scientific officer and associate professor of biology at Simpson University stated, “This important study uses actual Pfizer and Moderna clinical trial data to show that the risks of serious adverse events outweigh the benefits of these vaccines against COVID-19 hospitalization... the public, and public health officials, need to immediately consider the implications of these study results.”
Serious Adverse Events
The list of serious adverse events (SAEs) in Phase 3 trials included the following types: cardiac, dermatologic, endocrine, gastrointestinal, hematologic, liver, kidney, multisystem inflammatory syndromes, musculoskeletal, neurologic, ocular, respiratory and pregnancy. Peter Doshi, Ph.D., senior editor at The British Medical Journal (BMJ) and associate professor of pharmaceutical health services research at the University of Maryland School of Pharmacy related: “A systematic review and meta-analysis using individual participant data should be undertaken to address questions of harm-benefit in various demographic subgroups. Full transparency of the COVID-19 vaccine clinical trial data is needed to properly evaluate these questions. Unfortunately, well over a year after widespread use of COVID-19 vaccines, participant-level data remain inaccessible.”
No Research on Safety of COVID Vaccines
Researchers analyzed data from the clinical trials the Food and Drug Administration (FDA) used as the basis for granting Emergency Use Authorization of the Pfizer and Moderna vaccines “to investigate the association between FDA-authorized mRNA COVID-19 vaccines and serious adverse events identified by the Brighton Collaboration.” The handling of the priority list of adverse events of special interest for safety monitoring (AESIs) generated by the Brighton Collaboration and coordinated with the World Health Organization (WHO) was seriously flawed. The research team discovered that no research was ever conducted on clinical trial data to determine associatons between Pfizer or Moderna's COVID vaccines and AESIs.
Far More Severe Risk Than Benefit
The research team investigated serious adverse events (SAEs) included within the list of AESIs and found that the majority of SAEs were in fact AESIs--meaning most of the events were of particular safety concern. These findings contrasted with Pfizer's previous claim that nearly all SAEs during the vaccine clinical trials were "not related" to the vaccine. This was a blatant lie. Pfizer's vaccine documents finally released by the FDA on June 1, 2022 clearly show numerous instances of participants sustaining severe adverse events during Phase 3 trials. Some withdrew from the trials, some were dropped, and some died. According to the researchers, "In the Moderna trial, the excess risk of serious AESIs (15.1 per 10,000 participants) surpassed the risk reduction for COVID-19 hospitalization relative to the placebo group (6.4 per 10,000)... “In the Pfizer trial, the excess risk of serious AESIs (10.1 per 10,000) surpassed the risk reduction for COVID-19 hospitalization relative to the placebo group (2.3 per 10,000 participants).”
What Will They Do?
Clearly, the science shows that the mRNA shots cause dramatically more harm than benefit. We've always suspected it as a result of anecdotal evidence but now the proof has been laid out and published. How will it be received by the mainstream media and Dr. Fauci? When money is involved, I expect they will continue to ignore the truth.
1 Comment
|
BlogArchives
September 2024
Categories
All
|
© Angie's Option GRM. All rights reserved.